Small increases and decreases in pharmacy copayments have little influence on patients’ switching to generic drugs or on improving adherence to medication regimens. : To evaluate the effect on ...

The accompanying tables provide a snapshot of my 38-company Global Generic Drug Index, which is rapidly consolidating amidst a flurry of recent M&A activity -- including the following buyout offers: ...

The Food and Drug Administration, also on the defensive, has been quick to reassure consumers and Congress that its regulatory system of data review and inspections is effective regardless of where ...

The Medicines Patent Pool signed agreements March 17 with 35 generic drugmakers to manufacture Paxlovid, Pfizer’s COVID-19 antiviral pill, to advance the drug’s accessibility in 95 developing ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...

Viatris Inc. (NASDAQ:VTRS), a prominent player in the biopharmaceutical industry with a market capitalization of $9.73 billion, finds itself navigating a complex landscape of challenges and ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.74 billion, has been making significant strides in the pharmaceutical ...